<SEC-DOCUMENT>0000912282-14-000480-index.html : 20140811
<SEC-HEADER>0000912282-14-000480.hdr.sgml : 20140811
<ACCEPTANCE-DATETIME>20140808162855
ACCESSION NUMBER:		0000912282-14-000480
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20140808
FILED AS OF DATE:		20140808
DATE AS OF CHANGE:		20140808

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ONCOLYTICS BIOTECH INC
		CENTRAL INDEX KEY:			0001129928
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-31062
		FILM NUMBER:		141027804

	BUSINESS ADDRESS:	
		STREET 1:		1167 KENSINGTON CRES NW SUITE 210
		STREET 2:		CALGARY ALBERTA CANADA T2N 1X7
		CITY:			ALBERTA CANADA
		STATE:			A0
		ZIP:			00000
		BUSINESS PHONE:		4036707380

	MAIL ADDRESS:	
		STREET 1:		210 - 1167 KENSINGTON CRES NW
		CITY:			CALGARY
		STATE:			A0
		ZIP:			T2N 1X7
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>oncolytics6k_08082014.htm
<TEXT>
Document 1 - file: oncolytics6k_08082014.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>2
<FILENAME>ex99_3.htm
<DESCRIPTION>AMENDMENT TO PURCHASE AGREEMENT WITH LINCOLN PARK CAPITAL FUND, LLC DATED AUGUST 8, 2014
<TEXT>
Document 2 - file: ex99_3.htm

</DOCUMENT>
</SEC-DOCUMENT>